IQVIA HLDGS INC
| Market Cap | $29.40B |
| P/E Ratio | 22.13 |
| Forward P/E | 12.31 |
| Dividend Yield | — |
| Beta | 1.39 |
| 52W Range | $137.00 - $244.29 |
| # Hedge Funds | 5 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Hedge Fund Ownership
| Investor 5 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Bill Nygren Harris Associates LP | 3.22% | $2.55B | 11,319,718 | Reduce 0.59% |
| William Von Mueffling Cantillon Capital Management | 2.02% | $366.00M | 1,926,934 | — |
| David Tepper Appaloosa LP | 0.91% | $63.11M | 280,000 | Reduce 1.75% |
| Viking Global Investors Viking Global Investors | 0.37% | $139.58M | 619,236 | Buy |
| Thomas Gayner Markel Group | 0.08% | $10.57M | 46,900 | — |
Insider Trading
| Insider Name of the company insider who made the trade 15 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| BOUSBIB ARISee Remarks | Sale | 36,564 | $222.43 | $8.13M | 18 Dec 2025 | 19 Dec 2025 |
| Sherbet EricSee Remarks | Sale | 4,000 | $219.70 | $878.80K | 29 Oct 2025 | 31 Oct 2025 |
| BOUSBIB ARISee Remarks | Sale | 3,973 | $221.97 | $881.89K | 29 Oct 2025 | 31 Oct 2025 |
| BOUSBIB ARISee Remarks | Sale | 26,128 | $221.31 | $5.78M | 29 Oct 2025 | 31 Oct 2025 |
| BOUSBIB ARISee Remarks | Sale | 4,600 | $220.11 | $1.01M | 29 Oct 2025 | 31 Oct 2025 |
| BOUSBIB ARISee Remarks | Sale | 13,741 | $219.29 | $3.01M | 29 Oct 2025 | 31 Oct 2025 |
| BOUSBIB ARISee Remarks | Sale | 7,315 | $218.32 | $1.60M | 29 Oct 2025 | 31 Oct 2025 |
| BOUSBIB ARISee Remarks | Sale | 800 | $217.58 | $174.06K | 29 Oct 2025 | 31 Oct 2025 |
| Eric SherbetExecutive Vice President, General Counsel | Sale | 4,000 | $219.70 | $878.80K | 29 Oct 2025 | 31 Oct 2025 |
| Ari BousbibChairman, Chief Executive Officer & President | Sale | 3,973 | $221.97 | $881.89K | 29 Oct 2025 | 31 Oct 2025 |
| Ari BousbibChairman, Chief Executive Officer & President | Sale | 13,741 | $219.29 | $3.01M | 29 Oct 2025 | 31 Oct 2025 |
| Ari BousbibChairman, Chief Executive Officer & President | Sale | 7,315 | $218.32 | $1.60M | 29 Oct 2025 | 31 Oct 2025 |
| Ari BousbibChairman, Chief Executive Officer & President | Sale | 800 | $217.58 | $174.06K | 29 Oct 2025 | 31 Oct 2025 |
| Ari BousbibChairman, Chief Executive Officer & President | Sale | 26,128 | $221.31 | $5.78M | 29 Oct 2025 | 31 Oct 2025 |
| Ari BousbibChairman, Chief Executive Officer & President | Sale | 4,600 | $220.11 | $1.01M | 29 Oct 2025 | 31 Oct 2025 |
Frequently Asked Questions
What is IQV stock price today?
IQVIA HLDGS INC (IQV) is currently trading at $173.26. The stock has a 52-week range of $137.00 to $244.29 and a market capitalization of $29.40B.
Is IQV a good stock to buy in 2026?
IQVIA HLDGS INC has a P/E ratio of 22.1 (forward P/E: 12.3), a dividend yield of none, and 1-year performance of +3.3%. 5 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling IQV stock?
There have been 15 insider transactions for IQV in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has IQV stock performed over the past year?
IQVIA HLDGS INC (IQV) has returned +3.3% over the past 12 months. The stock traded between $137.00 and $244.29 during this period, and is currently at $173.26.
Which hedge funds own IQV (IQVIA HLDGS INC)?
5 tracked hedge funds currently hold IQV in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is IQV's market cap and valuation?
IQVIA HLDGS INC (IQV) has a market capitalization of $29.40B. The trailing P/E ratio is 22.1 and forward P/E is 12.3. The stock is classified in the Healthcare sector.
What is IQV's revenue and profitability?
IQVIA HLDGS INC reported revenue of $16.31B with net income of $1.36B and a profit margin of 0.08%. The stock has a beta of 1.39.
What sector is IQV in and who are its biggest institutional holders?
IQVIA HLDGS INC (IQV) operates in the Healthcare sector. It is held by 5 tracked hedge funds. See the ownership table above for the complete list.